SOHM Files Provisional Patent on ABBIE's 'Smart Gene-Editing' That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations -January 09, 2024 at 09:31 am EST

CHINO HILLS, Calif., Jan. 09, 2024 -- via IBN -- SOHM, Inc. , a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous...

Related Keywords

United States ,Chino Hills ,California ,India ,America ,David Aguilar ,Ioannis Prattis ,Patrik Gubeljak ,Gabrieles Kaminski Schierle ,Luigig Occhipinti ,Antonio Lombardo ,Los Angeles ,Ernestine Hui ,Ibn Sohm Inc ,Corporate Communications ,Sohm Inc ,Life Sciences Intelligence ,Life Sciences ,Sciences Intelligence ,Off Target Edits ,Delivery Efficiency ,Biosensing Applications ,Point Of Care Testing ,North America ,Latin America ,Harbor Statement ,Markets ,